Glucocorticoid receptors (GR) mediate the direct effects of glucocorticoids released in response to stress and the regulation of the hypothalamic-pituitary-adrenocortical (HPA) system through a negative feedback mechanism. Individuals with major mental illness, who often exhibit hypercortisolemia, may have down-regulated levels of GR mRNA. In situ hybridization for GR mRNA was performed on post-mortem specimens from patients suffering from depression, bipolar disorder, schizophrenia and from normal controls (n = 15 per group). In frontal cortex, GR mRNA levels were decreased in layers III-VI in the subjects with depression and schizophrenia. In inferior temporal cortex, GR mRNA levels were decreased in layer IV in all three diagnostic groups. In the entorhinal cortex, GR mRNA levels were decreased in layers III and VI in the bipolar group. In hippocampus, GR mRNA levels were reduced in the dentate gyrus, CA 4 , CA 3 and CA 1 in the schizophrenia group. In the subiculum, GR mRNA levels were reduced in the bipolar group. These results suggest that GR dysregulation occurs in all three major psychiatric illnesses with variability according to anatomical site. The severity and heterogeneity of this reduction may underlie some of the clinical heterogeneity seen in these disorders. Molecular Psychiatry (2002) 7, 985-994.
Introduction
Alterations in the limbic-hypothalamic-pituitary-adrenal axis (LHPA) of depressed patients are among the most widely reported findings in all of biological psychiatry. 1 Corticotropin releasing hormone (CRH) is released from neurons in the paraventricular nucleus of the hypothalamus. CRH stimulates production of adrenocorticotropin hormone (ACTH) in the anterior pituitary, which in turn stimulates cortisol release from the adrenal cortex. Corticosteroid receptors in the anterior pituitary and in limbic structures such as the hypothalamus, hippocampus and frontal cortex regulate LHPA function through a negative feedback mechanism. Cortisol has multiple physiological effects, 2 including enhancement of the physiological adaptation to stress.
The type II corticosteroid receptor, or glucocorticoid receptor (GR) has a low affinity for cortisol and mediates the feedback effects of high (stress-induced) levels of cortisol. Cortisol binds to GR, a ligand-activated transcription factor with protean effects on gene expression, including genes related to neuronal and glial metabolism, neuronal plasticity, and neurotransmission. [3] [4] [5] [6] [7] [8] Depressed patients often exhibit resting hypercortisolemia, and failure of appropriate negative feedback as measured by the dexamethasone suppression test. [9] [10] [11] [12] [13] [14] [15] There is considerable phenotypic overlap between unipolar depression, bipolar depression and some aspects of schizophrenia (flat affect, anhedonia and other negative symptoms). Subjects with bipolar disorder and schizophrenia also may have hypercortisolemia. 16, 17 These disorders may be associated with abnormal corticosteroid receptor function that contributes to a number of neuroendocrine abnormalities, similar to those recently described in transgenic mice expressing GR antisense RNA. 18, 19 Several studies have shown decreased radioligand binding to cytosolic GRs in depressed subjects, which may represent increased translocation of GRs to the nucleus, or an overall decrease in receptor number. [20] [21] [22] [23] However, few direct measurements of brain GR levels exist. A study examining GR mRNA in the hippocampus of six suicide victims who suffered from major depression, failed to reveal a significant decrease in GR mRNA. 15 A decrease in GR mRNA would have been predicted, since down regulation of GR mRNA expression is observed in the hippocampus and frontal cortex of rodents with hypercortisolemia. [24] [25] [26] Interpretation of post-mortem data is also complicated by potential effects of pre-mortem psychotropic drugs. 27, 28 To further investigate possible changes in the LHPA axis in individuals with mental illness, GR mRNA expression was examined in several brain areas strongly implicated in the pathogenesis of major mental illnesses. We included schizophrenia and bipolar disorder groups to determine the disease specificity of possible GR mRNA change.
Methods

Tissue
Frozen, 14 m thick coronal sections from Brodmann's area (BA) 46 (dorsolateral prefrontal cortex), BA 20 (inferior temporal gyrus), and medial temporal lobe structures at the level of the mid-hippocampus, were obtained from the Stanley Foundation Neuropathology Consortium (SFNC). The SFNC consists of 15 subjects with schizophrenia, 15 with bipolar disorder, 15 with major depression without psychotic features, and 15 normal controls. Details regarding the collection and storage of tissue and post-mortem diagnosis have been previously published. 29 All groups are matched for age, race, sex, and postmortem interval (Table 1) .
GR-riboprobe and northern analysis
The template used for preparing the human GR riboprobe corresponds to base pairs 26 through 2850 of the cDNA. 30 A 32 P-UTP labeled antisense riboprobe for GR, specific activity of 1 × 10 9 cpm g −1 was synthesized. Northern analysis was used to confirm the specificity of the GR probe for a 7.1 kB transcript in human cortical RNA. 30 A multiple tissue blot (Cat No. 7755-1, Clontech, Palo Alto, CA, USA) containing poly A mRNA from several brain regions (cerebellum, cerebral cortex, medulla, spinal cord, occipital pole, frontal lobe, temporal lobe, and putamen) of adult humans was used. The blot was prehybridized for 2 h with con- salmon sperm DNA, 0.025 M KPO 4 , 5× Denhardt's solution, 10% Dextran Sulfate and 5× SSC) and the mixture was pre-equilibrated to 42°C, added to the blots and incubated at 42°C overnight with continuous shaking. The blots were rinsed three times in 1× SSC/0.1% SDS at room temperature (15 min), three times in 0.25× SSC/0.1% SDS at 55°C (15 min), and three times in 0.2× SSC/0.1% SDS at 68°C (15 min). The blots were air dried and exposed to BioMax film for 7 h.
In situ hybridization
Fixation, acetylation, delipidation and dehydration of the tissue sections were performed as previously described. 31 Three hundred l of hybridization buffer containing the 35 S-UTP labeled GR riboprobe (at 5 ng ml −1 , specific activity = 1.7 × 10 9 cpm g −1 for frontal sections; 2.2 × 10 9 cpm g −1 for hippocampal slides) were added to each section and hybridized overnight at 55°C in humidified chambers. After the hybridization, RNase digestion, stringent washes and dehydration, the slides, along with 14 C standards (American Radiolabeled Chemicals, St Louis, MO, USA), were exposed to autoradiographic film (Biomax, Kodak) for 10 days. Nonspecific signal was determined by sense strand hybridization. These sections were treated identically to those receiving the antisense riboprobe. A subset of sections from normal control brains were dipped in photographic emulsion (Amersham LM1) and exposed for 11 weeks, developed and counterstained with thionin. All sections from each brain region were assayed together to prevent inter-assay variability.
Image analysis
Calibrated densitometric image analysis (NIH Image 1.33) of autoradiograms was conducted blind to diagnosis. BA 46 was delineated microscopically from Nissl-stained frontal sections based on the criteria of Rajkowska and Goldman-Rakic. 32 For autoradiograms obtained from each section, three randomly placed lines (230 M in width) were drawn perpendicular to the pial surface, traversing the entire cortical gray matter. Continuous optical density measurements were recorded along the length of these lines. The density of GR (in Ci g −1 of GR mRNA) as a function of cortical depth was computed from optical density data using the radioactive standards.
Data for individual cortical laminae in prefrontal cortex were obtained using the percentage of the total cortical width occupied by each layer, according to Rajkowska and Goldman-Rakic. 32 The percentage of full cortical width corresponding to the individual laminae were as follows: I (1-10%), II (11-18%), III (19-45%), IV (46-56%), V (57-72%), VI (73-100%).
The percent cortical depth occupied by individual cortical laminae was calculated from Nissl-stained sections from BA 20 in a similar manner. The percentage of full cortical width corresponding to the individual laminae were as follows: I (1-10%), II (11-20%), III (21-48%), IV (49-58%), V (59-70%), VIA (71-84%), VIB (85-100%).
Area ECL of entorhinal cortex was delineated from the Nissl stained sections according to the criteria of Insausti et al, 33 and percent cortical depth occupied by individual cortial laminae were calculated. The percentage of full cortical width corresponding to the individual laminae were as follows: I (1-12%), II (13-30%), III (31-65%), IV (none), V (66-76%), VI (77-100%). For hippocampal structures, mean optical density within several regions of interest (dentate gyrus granule cell layer, CA 4 , CA 3 , CA 1 , and subiculum) was determined.
Data and statistical analyses
A plot of GR density as a function of cortical width was generated for each subject, based on the mean of the three measurements made per subject. From this plot, a single measure of GR density for each subject was generated by calculating the area under the curve (AUC). AUC calculations were done with Number Cruncher Statistical Systems program (NCSS, Kaysville, UT, USA, 1999). AUC measurements for the diagnostic groups were compared using analysis of variance (ANOVA). For the hippocampus, the four diagnostic groups were compared using repeated measures ANOVA, with diagnosis as a between-group factor, and hippocampal subfield as a within-group factor.
In order to determine if demographic or descriptive variables other than diagnosis contributed significantly to the variance in GR mRNA density measurements, we first performed Spearman's rank order correlations between the AUC values (or raw OD values for the hippocampal subfields) and: post mortem interval; age; age of illness onset; lifetime exposure to neuroleptic drugs; illness duration; and pH. GR density was then compared between groups with analysis of covariance (ANCOVA) for any descriptive variable that contributed a significant proportion of variance in GR density measurements. The effects of non-continuous descriptive variables (cerebral hemisphere studied, gender, suicide, history of substance abuse or dependence,
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presence of antidepressant at time of death, or presence of neuroleptic treatment at the time of death) on GR density were assessed using Student's t-tests for unequal sample sizes assuming unequal variance.
We did not have a priori hypotheses regarding disease-related differences in GR density within specific cortical laminae. Nevertheless, we computed AUC measurements for individual cortical laminae in frontal and temporal neocortices, and in entorhinal cortex, in order to generate new hypotheses. These AUC measurements were made using the estimated percentage of cortical depth occupied by each lamina as described above. These values were compared for the diagnostic groups using repeated measures ANOVA, with diagnosis as a between-group factor, and layer as a within-group factor.
Results
Northern blot
Our GR riboprobe recognized one major transcript at 7.1 kb in RNA extracted from the human brain ( Figure 1) ; this is consistent with the reported size of full length GR mRNA transcript. 30, 34, 35 The 7.1 kb band was detected in both cortical and subcortical brain regions. However, the major GR transcript appeared to be most abundantly expressed in adult cerebellum. RNA extracted from the medulla and cortical areas showed intermediate levels of GR expression. The spinal cord and putamen give the weakest hybridization signal of the regions examined. Our GR riboprobe also hybridized to a 6.1 kb transcript that was expressed at low levels in all brain regions examined (Figure 1 ). These results suggest that there is significant regional variation in GR transcript expression in adult human brain and that multiple GR-like transcripts may be present in brain.
In situ hybridization GR mRNA was present in all regions examined. Hybridization signal was apparent over almost all pyramidal neurons and approximately 50% of nonpyramidal neurons. Signal was also apparent over at least 10% of glial cells (Figure 2 ). The autoradiographic films revealed a distinct laminar pattern for each cortical area. The hybridization signal was highest in layer VI of the frontal cortex (Figure 3,5a) , and in layer IV in the temporal cortex (Figure 4 ,5b). In contrast, the peak signal in the entorhinal cortex was in layers II and VI (Figure 4,5c ). In the hippocampus, hybridization signal was most robust over the granule cells of the dentate gyrus, although only 50-75% of all granule cells were labeled. The signal was relatively weak over the pyramidal cells of the CA 4 and CA 3 subfields, even though almost all were labeled (Figure 4 ). Approximately 10% of the glial cells were labeled throughout the hippocampal formation.
As previously reported in the rat brain, 36, 37 we found significant levels of GR mRNA hybridization in the 
Comparison of patient groups:
Analysis of variance of GR mRNA density in brain regions ANOVA with AUC data revealed a significant effect of diagnosis in BA 46 (F = 4.32, P Ͻ 0.01, df = 3,55). Post-hoc least significant differences (LSD) tests revealed significant differences between subjects with major depression compared to controls (P Ͻ 0.01), and subjects with schizophrenia compared to controls (P Ͻ 0.01). The reduction in GR density was approximately 25% for both depressed subjects and for schizophrenic subjects. There were no other significant differences between the diagnostic groups. Mean values for AUC in the full width of prefrontal cortex are shown in Figure 5a .
ANOVA with AUC data comparing the full cortical width of BA 20 was not significant (F = 1.45, P = 0.24, df = 3,53; Figure 5b ). For the entorhinal cortex, ANOVA reached the trend level of significance (F = 2.51, P = 0.07, df = 3,50; Figure 5c ).
For the hippocampus, repeated measures ANOVA revealed a significant effect of diagnosis (F = 3.68, df = 3,50, P = 0.02), a significant effect of hippocampal subfield (F = 182.2, df = 4,200, P Ͻ 0.0001), and a significant diagnosis by subfield interaction (F = 1.9, df = 12,200, P = 0.03) for GR mRNA levels. Post-hoc tests revealed that mean values for schizophrenic subjects were significantly reduced in the dentate gyrus (P Ͻ 0.01, −43%), CA 4 (P = 0.03, −43%), CA 3 (P Ͻ 0.01, −42%), and in CA 1 (P = 0.03, −35%), compared to the normal control group. Mean values for depressed subjects were reduced in the dentate gyrus (P = 0.03, −31%). Mean values for bipolar subjects were reduced in CA4 (P = 0.02, −44%), CA3 (P = 0.02, −24%) and subiculum (P = 0.01, −41%). All significant differences were between diagnostic groups and normal controls; there were no significant differences between schizophrenic and mood disorder subjects for any of the subfields. Mean values for the hippocampal subfields are shown in Figure 6 . for the three patient groups, and the normal controls, as a function of distance from the pial surface. Percentages on the x-axis refer to proportion of total cortical width occupied by specific laminae. Data from the entire cortical width were compared between groups using the area under the curve. *Post-hoc testing revealed schizophrenia and depression were significantly less than controls in layers III-VI, P Ͻ 0.01; post-hoc testing revealed all diagnostic groups were significantly reduced compared to controls in layer IV, P Ͻ 0.02; †Post-hoc testing revealed bipolar subjects significantly less than controls in layer III and VI, P Ͻ 0.004.
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Figure 6
Graph showing mean GR mRNA levels (Ci g −1 ) for the three patient groups and the normal controls in each hippocampal subfield. DG, dentate gyrus; *P Ͻ 0.05; **P Ͻ 0.01.
Effects of descriptive variables
There was a significant positive correlation between post-mortem brain pH and GR density in prefrontal (rho = 0.30, P = 0.02) and in inferior temporal cortex (rho = 0.44, P Ͻ 0.01). Post-mortem interval was significantly correlated with GR density in prefrontal cortex (rho = −0.26, P = 0.04). There were no other significant correlations between any of the cortical areas and: post-mortem interval; age; age of illness onset; lifetime exposure to neuroleptics; or illness duration. In the hippocampus, pH was significantly correlated with GR density in the dentate gyrus (rho = 0.40, P Ͻ 0.01) and in CA4 (rho = 0.29, P = 0.03). There was a significant correlation between post-mortem interval and GR density in CA3 (rho = −0.26, P = 0.05).
Since brain pH and post-mortem interval were significantly correlated with GR density measurements, ANCOVA was performed with these variables as covariates. This ANCOVA did not alter the statistical significance for the main effect or for the post-hoc tests in the prefrontal cortex. Results for the inferior temporal cortex remained statistically insignificant. Likewise, main effects and post-hoc tests were unchanged in the hippocampus, with the exception of the CA1 subfield. With pH and post-mortem interval added as covariates, the ANCOVA did not reach statistical significance (P = 0.052).
Effects of non-continuous variables Using Student's ttests GR density was compared for each of the brain regions measured for six dichotomous variables. There were no significant differences in any of the brain regions produced by: hemisphere (27 right and 33 left); gender (36 male and 24 females); history of suicide (n = 20); any history of substance abuse or dependence (n = 25); exposure to antidepressant at the time of death (n = 23); or exposure to neuroleptics at the time of death (n = 19).
Exposure to psychotropic drugs as a possible mechanism for altered GR mRNA levels was explored in greater detail. Subjects with a mental disorder receiving antipsychotics at the time of death (n = 19) were compared to subjects with mental disorders not receiving antipsychotics at time of death (n = 26), and to normal controls (n = 15). ANOVA revealed no differences between these groups. Similarly, ANOVA comparing patients on antidepressants at the time of death (n = 23), patients free of antidepressants at time of death (n = 22), and normal controls (n = 15) revealed no significant difference between groups. ANOVA comparing patients who committed suicide (n = 20), patients who did not commit suicide (n = 25), and normal controls (n = 15) revealed a significant group difference in prefrontal cortex (F = 8.9, P = 0.0004, df = 2, 56), but not in other areas. Post-hoc analysis revealed that GR mRNA density levels of patients who did not commit suicide were significantly decreased as compared to controls (P = 0.0005). There was no significant difference between patients who committed suicide and normal controls, or between patients who committed suicide and those who died by other means.
Exposure to antipsychotics and to antidepressants was also examined within each diagnostic group for evidence of alteration of GR mRNA levels. No significant differences were seen. t-Tests were conducted within each diagnostic group to compare GR mRNA levels of those patients who committed suicide to those who did not commit suicide. There was no effect of suicide in the groups with schizophrenia and depression, however in the group with bipolar disorder, those subjects committing suicide (n = 9) had GR mRNA levels significantly higher than those subjects who did not commit suicide (n = 6). This was true in the frontal cortex (P = 0.03), temporal cortex (P = 0.01), CA 4 (P = 0.008), and CA 3 (P = 0.01).
Effect of cortical laminae Repeated measures ANOVA with AUC data for individual cortical laminae in prefrontal, inferior temporal, and entorhinal cortex were performed as described above. In prefrontal cortex, there was a significant effect of diagnosis (F = 4.34, P Ͻ 0.01, df = 3,55), a significant effect of lamina (F = 453.95, P Ͻ 0.0001, df = 5,275), and a significant diagnosis by lamina interaction (F = 4.38, P Ͻ 0.0001, df = 15,275). Post-hoc testing confirmed that depressed subjects differed from normal controls in cortical layers III-VI (P Ͻ 0.01), and that schizophrenic subjects differed from normal controls in layers III-VI (P Ͻ 0.005).
In inferior temporal cortex there was no effect of diagnosis (F = 1.43, P = 0.25, df = 3,53). There was a significant effect of lamina (F = 393.80, P Ͻ 0.0001, df = 6,318), and a significant diagnosis by lamina interaction (F = 1.86, P = 0.02, df = 18,318). Post-hoc testing revealed that GR density was decreased compared to normal controls for bipolar, depressed, and schizophrenic subjects in layer IV (P Ͻ 0.02 for all groups).
In entorhinal cortex, there was no significant effect of diagnosis (F = 2.74, P = 0.06, df = 3,50). There was a significant effect of lamina (F = 222.05, P Ͻ 0.0001, df = 4,200), and there was a significant diagnosis by lamina interaction (F = 2.64, P = 0.002, df = 12,200). Post-hoc testing revealed that GR density was decreased for bipolar subjects in layers III (P = 0.003) and VI (P = 0.004).
Discussion
This paper presents the first comprehensive description of glucocorticoid receptor mRNA distribution in the frontal cortex and medial temporal lobe of subjects with major mental disorders. Interestingly, each diagnostic group has a unique pattern of GR mRNA abnormality. Whereas all diagnostic groups have a significant decrease in layer IV of temporal neocortex as compared to the normal controls, the subjects with schizophrenia have an additional decrease in multiple layers of frontal cortex, and throughout all the hippocampal subfields. Subjects with depression also have a decrease in GR mRNA density in frontal cortex, but in the hippocampus the reduction is restricted to the dentate gyrus. In contrast, subjects with bipolar disorder have decreased GR mRNA levels in the entorhinal cortex, subiculum, and CA4 and CA3 of the hippocampus.
We show that GR mRNA is expressed in neurons and glia of the frontal, temporal and entorhinal cortices with each displaying a distinct laminar pattern of GR mRNA hybridization signal. The intensity of the hybridization signal may simply reflect the relative density of neurons in the cortex since the signal is generally lowest in layer I and highest in layer IV. Consequently, it is possible that the decreased GR mRNA levels that we describe in the subjects with mental disorders, may reflect specific patterns of cellular pathology for these diseases. For example, the decrease in GR mRNA hybridization signal in the temporal neocortex could be due to a decrease in neuron density in temporal neocortex, perhaps with a more profound loss in layer IV granule cells. Currently, stereological studies of cell number in the brains of patients with mental disorders are limited and there is no definitive evi-dence for cell loss in the temporal neocortex of subjects with mental disorders. However, our findings in BA 46 would argue against a decrease in cell density as an explanation for the decrease in GR mRNA levels. We show that GR mRNA levels are decreased in layers III-VI in both the schizophrenia and depressed groups. In other post-mortem collections, neuron density is reportedly increased in layers II-IV and in layer VI of BA 46.
38 Neuron density therefore, is unlikely to explain the decrease in GR mRNA hybridization signal found in subjects with schizophrenia. In subjects with depression, Rajkowska et al 39 failed to reveal any overall changes in neuron density in frontal areas, BA 9 and 47, although they did not examine BA 46. Nevertheless, it is unlikely that the decrease in GR mRNA hybridization signal found in the BA 46 of subjects with schizophrenia and depression is a simple reflection of decreased neuron density.
GR hybridization is also found over glial cells, which are more evenly distributed throughout the cortex than neurons. The glial GR mRNA signal is therefore unlikely to contribute to laminar specific differences in GR mRNA hybridization density. However, it is possible that a selective decrease in glia could contribute to the decrease in the GR mRNA levels that we describe. While several studies have shown a decrease in glial density in frontal areas in both schizophrenia and depression, none have focused on BA 46. [39] [40] [41] [42] [43] [44] We found that GR mRNA was also expressed in both neurons and glia of the hippocampal formation. GR mRNA expression was quite robust in the dentate gyrus of the hippocampus, and relatively weak in the CA subfields, confirming previous descriptions by Seckl et al 45 and Lopez et al. 15 Several studies have shown a reduction in the volume of the hippocampal region in both schizophrenia [46] [47] [48] and in depression. 49, 50 While direct evidence for cell loss is weak 51, 52 the hippocampal shrinkage found in volumetric studies provides indirect evidence for loss of cells or neuropil. Thus, the decrease in GR mRNA that we find in the hippocampus may be a direct reflection of less neurons in the hippocampus of subjects with mental disorders. Detailed stereology studies of the hippocampus are needed to determine if there are indeed less cells in the hippocampus of patients with major mental disorders as compared to normal controls.
Interestingly, GR mRNA signal is markedly decreased in the entorhinal cortex and in the subiculum of subjects with bipolar disorder. The neurons of layers II and III in entorhinal cortex provide the main input to the hippocampus, whereas the subiculum is the main output of the hippocampus and projects back to layers V and VI of the entorhinal cortex. The subiculum also projects directly to the cingulate, dorsolateral prefrontal and orbital frontal cortices, as well as to the hypothalamus, septum, basal forebrain and anterior thalamus. The findings in schizophrenia are in direct contrast in that GR mRNA levels are decreased most markedly in the hippocampal subfields that are producing local connectivity.
Results from a recent in situ hybridization study anaMolecular Psychiatry lyzing synaptic proteins, complexin I and II, in the hippocampus of the SFNC, mirror those described here for GR mRNA. 53 Particularly striking is the significant decrease in each of the molecules in the subiculum of the bipolar subjects. Post hoc correlations between complexin mRNA levels (available through the SFNC data base) and GR mRNA levels for each hippocampal subfield revealed highly significant correlations, suggesting that LHPA alterations may be contributing to synaptic pathology. Increased levels of glucocorticoids resulting from 'stress', will not only lead to atrophy of dendrites of hippocampal pyramidal cells, and if prolonged, cell death, [54] [55] [56] but also to a decrease in neurogenesis in the hippocampal dentate gyrus. 57, 58 Moreover, glucocorticoids exert many of their effects on neuronal structure and function through the steroidregulated expression of gene products such as neurotrophic and growth-associated proteins, 59 -62 many of which are decreased in the brains of patients with schizophrenia. [61] [62] [63] [64] [65] [66] Thus, the increased cortisol levels described in patients with mental disorders 9-17 may contribute directly to the increased cell density, 38, 67 synaptic pathology, [68] [69] [70] [71] [72] [73] [74] [75] and perhaps even the decreased brain volumes [46] [47] [48] [49] [50] [76] [77] [78] [79] [80] [81] [82] that have been reported in patients with mental disorders.
Furthermore, the 'stress' associated with mental illness, may increase cortisol levels that then contribute directly to a decrease in GR expression. Previous animal studies have described a direct relationship between stress, increased glucocorticoids and decreased GR. 24, 26, 83 Thus, the decrease in GR mRNA levels that we observe in the subjects with mental disorders may relate to an acute effect of cortisol levels at the time of death. While many studies have demonstrated elevated cortisol levels in subjects with mental disorders during life, [9] [10] [11] [12] [13] [14] [15] [16] [17] there are no studies that have correlated cortisol levels at the time of death with mood state. While we have limited information about the mood state of our subjects at the time of death, many of those who committed suicide were clearly depressed. As a consequence, we could have predicted higher cortisol levels in these patients and thus decreased GR levels. It is surprising then to find that GR mRNA levels in the subjects who died by suicide were not significantly different from the normal controls, whereas patients who did not commit suicide had GR mRNA levels significantly lower than normal controls. Thus, the reduction in GR mRNA levels is more likely related to a chronic (life-time) alteration in LHPA functions. Such alterations may involve dysfunctional feedback loops, altered GR receptor sensitivities, and detrimental genetic variations in the GR gene, all of which may contribute to an altered relationship between 'stress' and GR expression in mental disorders.
Despite the fact that antidepressant treatment and mood stabilizing treatments increase GR numbers in both cultured cells and in the rodent brain, 27, 28, [84] [85] [86] [87] [88] we found no statistical relationship between antidepressant treatment and GR mRNA levels in our subjects in any of the areas examined. Antidepressants may exert their action on the HPA system via serotonergic postsynaptic activation 15, 18 or they may exert their effects on GR function more directly through stimulation of second messenger pathways known to regulate GR function. 89 All of the subjects with mental disorders, regardless of antipsychotic treatment, had significantly lower GR mRNA levels as compared to the fifteen control subjects. While there are no studies examining the effects of antipsychotics on GR mRNA levels, a recent study in primates receiving antipsychotic treatment, did not find a decrease in neuron or glial density measures 90 that would reflect the changes we see in GR mRNA levels. In fact glial density was increased as a result of antipsychotic treatment. 90 The findings suggest that the GR mRNA levels are decreased to varying degrees in the different brain areas in the three groups of patients with mental illness, perhaps because of a primary defect in the glucocorticoid receptors themselves that may be unique to the diagnosis. A reduction in the number of glucocorticoid receptors in the brains of subjects with mental disorders may make those brains more vulnerable to glucocorticoid mediated toxicity. 41 Depending on the degree to which the glucocorticoid receptors are reduced in a particular brain area, the response to an increase in cortisol may be different. The consequences of the anatomical variation in GR levels that occurs in these disorders may underlie some of the clinical heterogeneity that occurs.
Alternatively, the recent data, showing that high cortisol levels in patients with schizophrenia are correlated with higher ratings of positive symptoms, 91 have led Lupien 92 to suggest that positive symptoms and disorganized behavior cause the patients to have impaired encoding of information which then affects their capacity to discriminate between relevant (threat) and irrelevant (nonthreat) information. This further increases their reactivity to stress. This increased reactivity to stress will in turn lead to increased cortisol levels and decreased GR mRNA levels. In this scenario it is the underlying anatomical or biochemical defects in neuronal and glial activity and connectivity that leads to the LHPA abnormalities and subsequent decrease in GR mRNA levels. The significant decreases in GR mRNA levels in both the frontal cortex and hippocampus that we describe in schizophrenia reflect the large body of data that suggests serious anatomical, molecular and metabolic abnormalities in these regions in schizophrenic subjects 93, 94 and further supports the possible abnormalities in the interactions between the regions.
